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Abstract
It is known that deficiencies of micronutrients due to
infections increase morbidity and mortality. This phenomenon
depicts itself conspicuously in developing countries.
Deficiencies of iron, vitamins A, E, C, B12, etc are widely
prevalent among populations living in the third world
countries. Helicobacter pylori (H pylori) infection has a high
prevalence throughout the world. Deficiencies of several
micronutrients due to H pylori infection may be concomitantly
present and vary from subtle sub-clinical states to severe
clinical disorders. These essential trace elements/
micronutrients are involved in host defense mechanisms,
maintaining epithelial cell integrity, glycoprotein synthesis,
transport mechanisms, myocardial contractility, brain
development, cholesterol and glucose metabolism. In this
paper H pylori infection in associaed with various micronutrients
deficiencies is briefly reviewed.
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INTRODUCTION
Helicobacter pylori (H pylori)  is a gram negative,
microaerophilic human pathogen which colonizes the gastric
mucosa. Infection with H pylori leads to gastritis and is
associated with the development of peptic ulcer disease, gastric
carcinoma and lymphoma[1]. H pylori may be acquired at any
age, and the infection persists for years once acquired. The
age specific prevalence of H pylori infection is higher in
developing countries and particularly in lower socioeconomic
group[2]. In developing countries H pylori infection occurs early
in life, and hypochlorhydria commonly seen in the
malnourished predisposes them to repeated gastrointestinal
infection, persistent diarrhea and malnutrition[3]. H pylori
infection usually causes both acute and chronic inflammatory
cell infiltration, leading to an increase in reactive oxygen
species (ROS) which have been shown to accumulate in
H pylori gastritis[4]. Excessive production of reactive oxygen
metabolites (ROMs) by phagocytic cells is thought to
contribute to mucosal lesions produced by H pylori infection.
These are highly reactive compounds capable of combining
with DNA in a number of potentially genotoxic ways[5].
Reactive oxygen species can react with the lipid-bilayers
releasing peroxidation products such as malondialdehyde.
These processes could lead to alterations in the structure of
DNA facilitating mutations and carcinogenesis.
     Nutrition is a critical determinant of the outcome of host
microbe interactions through a modulation of the immune
response. “Micronutrient” or “trace elements” are generally
defined as constituting less than 0.01 % of body mass and are
needed in much smaller amounts. Trace minerals and vitamins
are essential for life and include iron (Fe), zinc (Zn), copper
(Cu), nickel (Ni), etc. They act as essential cofactors of enzymes
and as organizers of the molecular structures of the cell, e.g.
mitochondria and its membrane. Deficiencies of micronutrients
influence immune homeostasis and thus affect infection-related
morbidity and mortality. Micronutrients like b carotene, vitamin
C, selenium, copper and others are powerful antioxidants and
have a significant impact on infection related morbidity in
humans. Subclinical deficiencies are known to impair biological
and immune functions in the host. Antioxidants play a part in
gastric mucosal defense by protecting against damage caused
by excessive oxygen derived free radicals. b-carotene and a-
tocopherol are lipophilic and have been shown to suppress the
oxidation induced by either lipophilic or hydrophilic radical
species[6]. In addition, they could act as anti-carcinogens through
their ability to prevent the formation of N-nitrosamines which
are important in the development of gastric carcinoma[7]. These
vitamins are the major oxidant scavengers in biomembranes in
contrast to vitamin C, which is mainly responsible for
scavenging free radicals in the aqueous phase. However,
compensatory mechanisms may become defective while gastric
inflammation develops from normal to chronic gastritis and
finally to gastric atrophy/intestinal metaplasia, perhaps due to
reduced infiltration of inflammatory cells, loss of gastric gland
cells and increased ROM production.
IRON
Iron deficiency anemia affects all groups of the under
privileged population in most developing countries. Iron is an
essential growth factor for H pylori, which contains Fe in their
outer membrane protein and a system for intracellular storage
of iron, consisting of ferritin like molecules pfr and napA[8].
Patients with H pylori associated iron deficiency anemia (IDA)
would have involvement of both antral and corporal mucosa
when compared with controls (90 % vs 42.7 %; P=0.0001)[9].
Iron deficiency anemia associated with H pylori gastritis is
characterized by a concomitant increase in median intragastric
pH value >3 and lowering of intragastric concentrations of
ascorbic acid. A significant percentage (43 %) of H pylori
positive IDA patients presented atrophic changes in the
gastric body, and the remaining had a superficial gastritis
extended to the fundic mucosa, in contrast with H pylori
positive controls[10]. H pylori eradication has also been shown
to improve the absorption of other nutrients besides iron, and
produce more rapid and complete clinical responses in patients
with iron deficiency anemia[11].
COPPER
Copper is involved in the function of several enzymes. It is
required for infant growth, host defense mechanisms, bone
strength, red and white cell maturation, iron transport, etc.
Acquired deficiency is mainly seen in infants. However, it has
been diagnosed also in malnourished children and adults[12]. A
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gene, copA, associated with copper transport, has been isolated
from H pylori UA802. The adenosine triphosphatase-derived
copper-transporting mechanism is employed by various
H pylori strains[13]. As a cofactor in various redox enzymes
and an essential trace metal required for the synthesis of
metalloproteins, copper plays a role in the pathogenesis of
H pylori. H pylori has a differential effect on some gastric
mucosal scavenger enzymes of ROMs, namely mitochondrial
and cytoplasmic superoxide dismutases reflected by a large
increase in the cytokine inducible manganese superoxide
dismutase and a decrease in the constitutive copper/zinc
superoxide dismutase[14].
VITAMIN B12
The mechanisms of vitamin B12 malabsorption caused by
H pylori infection are unclear but following are the possibilities:
a) The diminished acid secretion in H pylori induced gastritis
may lead to a failure of critical splitting of vitamin B12 from
food binders and its subsequent transfer to R binder in the
stomach. b) A secretory dysfunction of the intrinsic factor. c)
Decreased secretion of ascorbic acid from the gastric mucosa
and increased gastric pH[15,16]. Annibale et al, studied the
prevalence of H pylori infection in pernicious anemia patients
and have demonstrated that almost two thirds of pernicious
anemia patients had evidence of H pylori but only those with
an active H pylori infection had distinctively functional and
histological features[17]. These findings support the hypothesis
that H pylori infection could play a triggering role in a subgroup
of pernicious anemia patients, and suggest the possibility that
H pylori is involved in the early stages of PA that lead to
severe corpus atrophy. The later progress of gastritis seems to
be dependent on factors other than H pylori, most likely
“autoimmune” mechanisms[18]. H pylori may also be involved in
the pathogenesis of pernicious anemia via antigenic mimicry as
antibodies directed against the H+, K+- adenosine-triphosphate
protein that has been found in high numbers of patients with H
pylori infection[19]. Food cobalamin malabsorption may occur
without gastric atrophy or achlorhydria. Malabsorption can
respond to antibiotics, but only in some patients[20].
VITAMIN A
Vitamin A has effects on important determinants of immune
function and epithelial cell integrity such as gene expression,
cellular proliferation and differentiation and also glycoprotein
synthesis. Loss of integrity of the epithelial lining of mucus
membranes in a vitamin A deficient state could explain its close
association with increased susceptibility to infections
particularly of gastrointestinal, respiratory and genitourinary
tracts especially in children and pregnant women[21]. Even mild
or subclinical vitamin A deficiency could induce keratinizing
metaplasia of the epithelium and depletes goblet cells from
mucosal linings thus causing xerosis of the membrane[22]. The
xerotic surfaces form potential sites for increased bacterial
adherence thus leading to bacterial colonization. The
antimicrobial enzyme lysozyme depends on vitamin A for its
synthesis. A decrease in T cell number with no change in
proliferative activity has been demonstrated in children
suffering from mild xerophthalmia due to vitamin A deficiency.
H pylori infection and low b-carotene in plasma contribute to
the increased risk of gastric atrophy, indicating that H pylori
infection might be associated with low plasma b-carotene[23].
VITAMIN E
Vitamin E is composed of a group of compounds termed
tocopherols and tocotrienols. a-tocopherol is the major active
form in the human body, accounting for 95 % of vitamin E and
is the most effective lipid soluble anti-oxidant in biomembranes.
It acts as the major chain breaking antioxidant and is able to
interfere with the propagation of lipid peroxidation. It plays an
immune modulatory part and is capable of increasing natural
killer cell activity. Concentrations of a-tocopherol in H pylori
negative subjects were higher in the corpus than in the antrum
or duodenum[6]. This distribution of a-tocopherol is reversed
in the presence of antral H pylori infection. These findings
may reflect a mobilization of antioxidant defenses to the sites
of maximal inflammation in the stomach.
VITAMIN C
Vitamin C exists as ascorbic acid (AA) or dehydroascorbic
acid. The stomach secretes ascorbic acid across the gastric
mucosa into the gastric juice against a concentration gradient.
Ascorbic acid is the reduced form of the vitamin and can act
as a potent antioxidant, and is able to scavenge ROS in gastric
mucosa. This has been proposed as one means by which it
exerts an anti-carcinogenic effect. Ascorbic acid may also
prevent formation of N-nitroso compounds in gastric juice by
scavenging nitrite. It has been observed that diets poor in foods
containing AA were associated with an increased risk of gastric
cancer[24]. Wei-cheng et al showed that presence of H pylori
infection at the baseline and smoking were strongly associated
with progression to dysplasia or gastric cancer, whereas the
risk of progression was decreased by 80 % among subjects
with baseline ascorbic acid levels in the highest tertile compared
with those in the lowest tertile[25]. A number of studies have
demonstrated that gastric juice but not gastric mucosal AA
levels were reduced in the presence of H pylori gastritis and that
successful eradication restored the juice/plasma AA ratio[23, 26].
The lower plasma AA concentration in H pylori positive
subjects could be due to reduced bioavailability, active
secretion from plasma to gastric juice in attempts to restore the
positive gastric juice/plasma ratio or both[27]. In some studies
no difference was found in the gastric juice AA concentration
between patients with antral-limited gastritis and H pylori
negative healthy controls, while lower AA levels were observed
in patients with gastric body involvement and increased pH[28].
These observations suggest that AA, which is very unstable
in the presence of increased pH, is converted to the less active
form of dehydroascorbic acid, in the presence of gastric damage
extending to the corporal mucosa with consequent
hypochlorhydria [29,30].  It has been demonstrated that
eradication of H pylori could lead to a reduction in ROS activity
in gastric mucosa[31]. Ascorbic acid has also been shown to
inhibit H pylori urease activity and growth in vitro[32]. H pylori
infection associated low gastric juice-ascorbic acid levels return
to normal after successful eradication of the infection[33]. A
study of antibiotic treatment failure showed that compliant
patients in whom H pylori infection did not clear had lower
baseline plasma and gastric juice vitamin C concentrations than
patients whose infection was cleared[26].
      In developing countries micronutrient deficiencies facilitated
by H pylori infection are a clinical and public health problem. It
is essential to define the precise extent of the problem. Several
micro and macronutrient deficiencies could be concomitantly
present in the population with several other deficits. They will
require correction to achieve significant effects on the over all
health of the population.
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